Cladribine is a medication used to treat hairy cell leukemia (HCL, leukemic
reticuloendotheliosis) and B-cell chronic lymphocytic leukemia. Its chemical
name is ...
(KLA-drih-bean). Trade name: Leustatin<sup>TM</sup> Other names: 2-CdA, 2-
Chlorodeoxyadenosine. Cladribine is the generic name for the trade name drug
Sep 11, 2015 ... Cladribine is a type of chemotherapy that belongs to a class of drugs called
antimetabolites. These medications are taken up by cells and are ...
Jun 15, 2016 ... Cladribine injection must be given in a hospital or medical facility under the
supervision of a doctor who is experienced in giving chemotherapy ...
My father 60 years, was given 5-day Cladribine from March 30-April 3. His blood
counts almost after 2 months are around TLC- 2000, Hg- 8.9, Platelets- 52000, ...
Cladribine differs structurally from deoxyadenosine only by the presence of a
chlorine atom at position 2 of the purine ring, which results in resistance to ...
Apr 12, 2016 ... Find a comprehensive guide to possible side effects including common and rare
side effects when taking Leustatin (Cladribine Injection For ...
Cladribine mechanism of action. 2-CdA enters the cell through an efficient
transport system. Cladribine is resistant to deamination by ADA. The high DCK to
Abstract. Hairy cell leukemia is a chronic B-cell disorder that follows an indolent,
but progressive course. Cladribine (2-chlorodeoxyadenosine) induces complete
Find out more about cladribine (Leustat ®, LITAK ®), a chemotherapy drug used
to treat hairy cell leukaemia and B-cell chronic lymphocytic leukaemia (CLL)